Replies to post #16435 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

Opportunity, I remember when those patents were posted. Abbott listed every antibody and biomarker they had access to in those patents.

For Abbott to be doing any work with RECAF WHAT SO EVER, they would have to give notice to BioCurex and resume paying minimum royalties, milestones, etc. The amended agreement is only a few months old and much more current than anything stated in previous patents in regard to markers Abbott had at the time of application.